APOTEX, INC. v. CEPHALON, INC. et al

Filing 997

MEMORANDUM OPINION ORDER THAT MYLAN LABORATORIES, INC., MYLAN PHARMACEUTICALS, INC., RANBAXY LABORATORIES, LTD. AND RANBAXY PHARMACEUTICALS, INC.'S MOTION TO STAY PROCEEDINGS (DOC. NO. #923 ), IS DENIED WITH RESPECT TO THE DIRECT PURCHASERS AND APOTEX. IN LIGHT OF THE AGREEMENT BETWEEN THE PARTIES, THE MOTION IS GRANTED WITH RESPECT TO THE END PAYORS ONLY AND THE CLERK OF COURT SHALL MARK C.A. NO. 06-1833 CLOSED FOR STATISTICAL PURPOSES AND PLACE THAT MATTER IN THE CIVIL SUSPENSE FILE. SIGNED BY HONORABLE MITCHELL S. GOLDBERG ON 12/17/2015. 12/17/2015 ENTERED AND COPIES MAILED AND E-MAILED.(amas)

IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
______________________________________________________________________________
:
KING DRUG COMPANY OF FLORENCE, INC., :
CIVIL ACTION
et al.,
:
Plaintiffs,
:
:
v.
:
No. 2:06-cv-1797
:
CEPHALON, INC., et al.,
:
Defendants.
:
_________________________________________ :__________________________________
:
VISTA HEALTHPLAN, INC., et al.,
:
CIVIL ACTION
Plaintiffs,
:
:
v.
:
No. 2:06-cv-1833
:
CEPHALON, INC., et al.,
:
Defendants.
:
_________________________________________ :__________________________________
:
APOTEX, INC.,
:
CIVIL ACTION
Plaintiff,
:
:
v.
:
No. 2:06-cv-2768
:
CEPHALON, INC., et al.,
:
Defendants.
:
_________________________________________ :___________________________________
ORDER
AND NOW, this 17th day of December, 2015, upon consideration of “Mylan
Laboratories, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd. and Ranbaxy
Pharmaceuticals, Inc.’s Motion to Stay Proceedings Pending Decision on Their Rule 23(f)
Appeal” (Dkt. No. 06-1797, Doc. No. 871; Dkt. No. 06-1833, Doc. No. 470; Dkt. No. 06-2768,
Doc. No. 923), the responses and reply thereto, and following oral argument and an on-therecord telephone conference, it is hereby ORDERED that the motion is DENIED with respect
1

to the Direct Purchasers (including the Individual Plaintiffs1) and Apotex. The liability trial
scheduled for February 2, 2016 will proceed with respect to those parties.
It is further ORDERED that, in light of the agreement between the parties, the motion is
GRANTED with respect to the End Payors only and the Clerk of Court SHALL mark Vista
Healthplan, Inc., et al. v. Cephalon, Inc., et al. (No. 2:06-cv-1833) closed for statistical purposes
and place that matter in the Civil Suspense File.
.
BY THE COURT:
/s/ Mitchell S. Goldberg, J.
______________________________
Mitchell S. Goldberg, J.

1

The Individual Plaintiffs are owners and operators of retail pharmacies who have filed their
own separate actions, and are excluded from the definition of the Direct Purchaser Litigation
Class.
2